Comment & analysis
Pharma use loophole to hike up the price of drugs – so why doesn’t the NHS stop it?
We should be asking what a recent expose of drug price rises tells us about how health is being managed in the UK, argues Chris Ford.
Targets to bring women into the boardroom are missing the point
Swarnodeep Homroy and Colin Green argue that quotas do not necessarily solve the underlying cause of gender inequality.
Lessons from VW
Professor Bryan Lukas, from Lancaster's Marketing department, talks about what we can learn from the VW emissions scandal from a branding perspective.
Clinton’s anti-drugmaker rhetoric may win votes, but does it threaten our long-term health?
Clinton, who named drug companies among her enemies in this week's debate, is pushing policies that could hamper the flow of new medicines, argues Chris Ford in The Conversation.
How data empowered the economic individual and gained a Nobel for Angus Deaton
This year's award recognises the value of micro analysis and good, old-fashioned legwork, argues Dr Vincent O'Sullivan.
Too many smart northerners leave for London
In the Independent, LUMS's Dr Vincent O'Sullivan and Dr Hakim Yadi, Chief Executive of the Northern Health Science Alliance, argue that any Northern Powerhouse must try to bring talented graduates back from the capital.Read the article on The Independent website